News
In addition to announcing the appointment of NICHD’s new deputy director, Dr. Bianchi provides updates on the NICHD Strategic Plan and phase two of the Task Force on Research Specific to Pregnant Women and Lactating Women.
After a nationwide search, Alison Cernich, Ph.D., has been selected as NICHD Deputy Director. Since 2015, Dr. Cernich has served as the director of NICHD’s National Center for Medical Rehabilitation Research.
Infants born to mothers taking the drug naltrexone to treat opioid use disorder showed no signs of drug withdrawal and had shorter hospital stays than infants born to mothers undergoing the standard treatment, according to a small NICHD-funded study.
Carriers of the FMR1 premutation—a mutation in the gene associated with the developmental disorder Fragile X syndrome—may be at higher risk for several health conditions, according to an analysis funded by NIH.
Exposure to high levels of certain common air pollutants in early pregnancy may increase the risk of high blood pressure, suggests an analysis by researchers at NICHD.
A pregnant women’s genetic risk score for cholesterol and other blood lipids is linked to fetal weight, but varies according to the woman’s racial and ethnic group and obesity status, suggests an analysis by NICHD researchers.
Inherited genetic factors account for approximately 80 percent of the risk for autism spectrum disorder, according to a study funded by NIH.
NICHD supports a variety of resources and tools for researchers.
Featured this Month:
NICHD is a member of the NIH Pain Consortium, which aims to enhance pain research and promote collaboration on pain-related research across NIH. NICHD’s interests in pain-related research cross a variety of populations, including children, women of reproductive age, pregnant and lactating women, and people with disabilities. The consortium’s efforts complement activities conducted within NIH's HEAL (Helping to End Addiction Long-termSM) Initiative.